Vimta Labs (VIMTALABS) | Stock Overview & Key Data
Vimta Labs Performance Comparison
Stock Range
Today's Range
Low: ₹710.40
High: ₹744.90
on October 3, 2025
52 Week Range
Low: ₹251.52
High: ₹902.65
on October 8, 2024
on September 5, 2025
All-Time High: ₹1,178.00 on February 10, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR33.1B
EPS
15.15
P/E Ratio (TTM)
46.63
Forward P/E
N/A
P/B Ratio
8.29
PEG Ratio
-2.00
Div. Yield
0.83%
ROE
17.78%
Beta
-0.261
Debt to Equity
2.25
Financial Highlights
Profitability
Gross Margin
80.72%
Operating Margin
24.42%
Profit Margin
19.93%
Returns and Earnings
Return on Assets (TTM)
14.43%
Return on Equity (TTM)
17.78%
EBITDA
INR1.4B
Net Income (TTM)
INR717.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR82.77
Quarterly Revenue Growth (YoY)
19.30%
Quarterly Earnings Growth (YoY)
53.90%
Dividend Information
Last 12-Month Dividend
₹4.00
Current Dividend Yield
0.83%
3-Year Average Dividend Yield
0.44%
3-Year Average Annual Dividend
₹2.00
3-Year Total Dividends
₹6.00
Ex-Dividend Date
May 30, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Vimta Labs VIMTALABS | 33.11B Small-cap | 1.58% | -8.86% | 55.76% | 35.52% | 49.71% | 180.25% | 327.46% | 1,084.24% |
| Dr. Lal PathLabs LALPATHLAB | 266.14B Large-cap | -2.09% | -6.29% | 13.46% | 24.37% | 2.45% | -10.52% | 28.09% | 52.23% |
| Syngene SYNGENE | 250.35B Large-cap | -3.23% | -1.94% | -2.51% | -13.27% | -29.16% | -28.05% | 10.41% | 11.27% |
| Krsnaa Diagnostics KRSNAA | 25.26B Small-cap | -4.33% | -5.70% | 6.86% | -3.27% | -16.67% | -10.78% | 49.72% | -18.11% |
| Suraksha Diagnostic SURAKSHA | 16.14B Small-cap | 0.40% | -1.30% | -7.10% | 4.82% | -21.28% | -28.29% | -28.29% | -28.29% |
| Qualitek Labs QLL | 4.84B Small-cap | 3.75% | 9.21% | 36.07% | 59.00% | 13.13% | 17.73% | 168.09% | 168.09% |
Ownership & Short Interest
Insider Ownership
66.66%
Institutional Ownership
3.16%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2M
Average 90-Day Volume
3M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VIMTALABS's 52-week high and low?
- In the last 52 weeks, Vimta Labs reached a high of ₹902.65 (on September 5, 2025) and a low of ₹251.52 (on October 8, 2024).
- What is the market cap and P/E ratio for VIMTALABS?
- Curious about Vimta Labs's size and valuation? Its market capitalization stands at 33.11B. When it comes to valuation, the P/E ratio (trailing twelve months) is 46.63, and the forward P/E (looking ahead) is N/A.
- Does VIMTALABS pay dividends? If so, what's the yield?
- Yes, Vimta Labs is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.83%, and the company has paid an average of ₹2.00 per share annually over the past 3 years.
- Who are Vimta Labs's main competitors or similar companies to consider before investing?
When looking at Vimta Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB266.14B Healthcare Diagnostics & Research -10.52% 28.09% Syngene
SYNGENE250.35B Healthcare Diagnostics & Research -28.05% 10.41% Krsnaa Diagnostics
KRSNAA25.26B Healthcare Diagnostics & Research -10.78% 49.72% Suraksha Diagnostic
SURAKSHA16.14B Healthcare Diagnostics & Research -28.29% -28.29% Qualitek Labs
QLL4.84B Healthcare Diagnostics & Research 17.73% 168.09% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vimta Labs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Vimta Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.78%, the Debt to Equity ratio from the most recent quarter is 2.25, and its Gross Profit Margin stands at 80.72%.
- What is the recent revenue and earnings growth for VIMTALABS?
- Looking at Vimta Labs's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.30%, and quarterly earnings saw a YoY growth of 53.90%.
- How much of VIMTALABS stock is held by insiders and institutions?
- Wondering who owns Vimta Labs stock? Company insiders (like executives and directors) hold about 66.66% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.